We are all in for improved health as a leading global provider of generic medications with a robust and innovative range.
For almost a century and a half, Teva Pharmaceuticals has been creating and manufacturing medications. We have a strong position in the generics market in addition to conducting extensive research and running large operations to support our expanding line of novel medications and biopharmaceutical goods.
We currently have one of the greatest product portfolios of any pharmaceutical company in the world, with almost 3,600 goods. Every day, about 200 million individuals across 60 countries receive superior medications from Teva. We continue the tradition of more than a century of discovering novel approaches to assist patients in improving their lives by investing in the research and development of cutting-edge medications, generic medications, and biosimilars.
Encouraging patients to live longer, better lives has been our goal since Teva was founded in Jerusalem in 1901. While we strive to address the most pressing healthcare issues of the future, we are proud of our modest origins and previous achievements.
Chaim Salomon, Moshe Levin, and Yitschak Elstein could not have predicted that their modest pharmaceutical company would grow to become a global leader in its field when they first met in Jerusalem more than a century ago.
Having come a long way from our modest beginnings to influencing the global generic medicine market, we are now starting a new chapter in the biopharmaceutical history. Since Teva was founded more than a century ago, a lot has happened in the healthcare industry. What hasn't changed, though, is our steadfast commitment to providing creative and approachable solutions that promote better living.